9 Yes, 8 No, 1 Abstain. Its just a hair-line escape. Iam sure US partnership will not happen in this uncertainty. FDA will also not give approval in this margin.
Who suggested the revised question (single dosage) that the panel voted in favor of? Did Alexza management suggest the revised question? No. Did any of the panel members suggest it? No. Who do you think suggested the revised question?
I have stopped explaining it to them. They just don't get it. If they are serious about their statements, then most of them have not followed the live panel meeting today.
The FDA, of course. Now why would they do that? Ahem
The expectation was that ALXA would not pass, thats why this stock was being punished . Unfairly in my opinion.So for the Panel to even allow it to pass, even though marginally is indication that there's more work to be done but more importantly this aint NO DEAD CAT.So the price tomorrow ought to adjust up...not to 2 dollars but definitely to $1 give or take....its not a big celebration but its a big sigh of relief, especially for us Longs.
"""If Adasuve gains FDA approval, Alexza “would still need a U.S. partner and/or to raise substantial cash to fund the launch of Adasuve, which should limit near-term upside,” Kantor said."""This is the reality. May be green for few hrs IMO.
You are so phunny. :):)